_id
6919f5d53c536f8df2318762
Ticker
NN6.XETRA
Name
NanoRepro AG
Exchange
XETRA
Address
Untergasse 8, Marburg, Germany, 35037
Country
Germany
Sector
Healthcare
Industry
Diagnostics & Research
Currency
EUR
Website
https://www.nanorepro.com
Description
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. It offers rapid diagnostic tests, such as family planning, and preventive healthcare line products. The company also develops and commercializes immunochromatographic lateral flow tests; and tests for hospitals and medical practices. The company is headquartered in Marburg, Germany.
Last Close
1.52
Volume
1191
Current Price
1.58
Change
-0.986842105263166
Last Updated
2025-12-30T12:16:49.968Z
Image
https://logo.clearbit.com/www.nanorepro.com
Ipo Date
-
Market Cap
19172180
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
2426297
Cost Of Revenue
1789879
Gross Profit
636417
Operating Expenses
1576192
Operating Income
-939777
Interest Expense
-
Pretax Income
-843695
Net Income
-843695
Eps
-0.06688944252072182
Dividends Per Share
-
Shares Outstanding
12613276
Income Tax Expense
-
EBITDA
-811196
Operating Margin
-38.73297456988984
Total Other Income Expense Net
96082
Cash
7289782
Short Term Investments
-
Receivables
427673
Inventories
465924
Total Current Assets
10094947
Property Plant Equipment
348660
Total Assets
37991789
Payables
151773
Short Term Debt
-
Long Term Debt
-
Total Liabilities
694207
Equity
37297581
Bs_currency_symbol
EUR
Depreciation
32503
Change In Working Capital
2005799
Cash From Operations
2052000
Capital Expenditures
26400
Cash From Investing
-3860400
Cash From Financing
-
Net Change In Cash
-1808340
Cf_currency_symbol
-
PE
-
PB
0.5343235551924936
ROE
-2.2620635906655715
ROA
-2.220729852969019
FCF
2025600
Fcf Percent
0.8348524521111801
Piotroski FScore
2
Health Score
53
Deep Value Investing Score
7.5
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
4
Growth Investing Score
2.5
Momentum Investing Score
3
Net Net Investing Score
4.5
Quality Investing Score
4.5
Value Investing Score
7
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
2426297
Quarters > 0 > income Statement > cost Of Revenue
1789879
Quarters > 0 > income Statement > gross Profit
636417
Quarters > 0 > income Statement > operating Expenses
1576192
Quarters > 0 > income Statement > operating Income
-939777
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-843695
Quarters > 0 > income Statement > net Income
-843695
Quarters > 0 > income Statement > eps
-0.06688944252072182
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
12613276
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-811196
Quarters > 0 > income Statement > operating Margin
-38.73297456988984
Quarters > 0 > income Statement > total Other Income Expense Net
96082
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
7289782
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
427673
Quarters > 0 > balance Sheet > inventories
465924
Quarters > 0 > balance Sheet > total Current Assets
10094947
Quarters > 0 > balance Sheet > property Plant Equipment
348660
Quarters > 0 > balance Sheet > total Assets
37991789
Quarters > 0 > balance Sheet > payables
151773
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
694207
Quarters > 0 > balance Sheet > equity
37297581
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-843695
Quarters > 0 > cash Flow > depreciation
32503
Quarters > 0 > cash Flow > change In Working Capital
2005799
Quarters > 0 > cash Flow > cash From Operations
2052000
Quarters > 0 > cash Flow > capital Expenditures
26400
Quarters > 0 > cash Flow > cash From Investing
-3860400
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-1808340
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.06688944252072182
Quarters > 0 > ratios > PB
0.5343235551924936
Quarters > 0 > ratios > ROE
-2.2620635906655715
Quarters > 0 > ratios > ROA
-2.220729852969019
Quarters > 0 > ratios > FCF
2025600
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.8348524521111801
Quarters > 0 > health Score
53
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
2739490
Quarters > 1 > income Statement > cost Of Revenue
1145764
Quarters > 1 > income Statement > gross Profit
1593726
Quarters > 1 > income Statement > operating Expenses
2966719
Quarters > 1 > income Statement > operating Income
-1372993
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-869004
Quarters > 1 > income Statement > net Income
-880332
Quarters > 1 > income Statement > eps
-0.06979408045935093
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
12613276
Quarters > 1 > income Statement > income Tax Expense
11328
Quarters > 1 > income Statement > EBITDA
-1352690
Quarters > 1 > income Statement > operating Margin
-50.11856221413474
Quarters > 1 > income Statement > total Other Income Expense Net
503989
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
9098122
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
545828
Quarters > 1 > balance Sheet > inventories
901400
Quarters > 1 > balance Sheet > total Current Assets
14956357
Quarters > 1 > balance Sheet > property Plant Equipment
347360
Quarters > 1 > balance Sheet > total Assets
39025310
Quarters > 1 > balance Sheet > payables
216123
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
884033
Quarters > 1 > balance Sheet > equity
38141276
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-880332
Quarters > 1 > cash Flow > depreciation
20304
Quarters > 1 > cash Flow > change In Working Capital
261100
Quarters > 1 > cash Flow > cash From Operations
789800
Quarters > 1 > cash Flow > capital Expenditures
280700
Quarters > 1 > cash Flow > cash From Investing
-15477600
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-14687803
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.06979408045935093
Quarters > 1 > ratios > PB
0.522504178412909
Quarters > 1 > ratios > ROE
-2.3080821942087097
Quarters > 1 > ratios > ROA
-2.2557975836707
Quarters > 1 > ratios > FCF
509100
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.18583750990147802
Quarters > 1 > health Score
51
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
1771047
Quarters > 2 > income Statement > cost Of Revenue
1487992
Quarters > 2 > income Statement > gross Profit
283055
Quarters > 2 > income Statement > operating Expenses
2534875
Quarters > 2 > income Statement > operating Income
-2251826
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-1869418
Quarters > 2 > income Statement > net Income
-1165426
Quarters > 2 > income Statement > eps
-0.09239677305087116
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
12613276
Quarters > 2 > income Statement > income Tax Expense
-703991
Quarters > 2 > income Statement > EBITDA
-1861277
Quarters > 2 > income Statement > operating Margin
-127.14659746466357
Quarters > 2 > income Statement > total Other Income Expense Net
382408
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
23785925
Quarters > 2 > balance Sheet > short Term Investments
2012425
Quarters > 2 > balance Sheet > receivables
278282
Quarters > 2 > balance Sheet > inventories
875568
Quarters > 2 > balance Sheet > total Current Assets
31064588
Quarters > 2 > balance Sheet > property Plant Equipment
81910
Quarters > 2 > balance Sheet > total Assets
39749221
Quarters > 2 > balance Sheet > payables
314334
Quarters > 2 > balance Sheet > short Term Debt
1
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
727613
Quarters > 2 > balance Sheet > equity
39021607
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-1165426
Quarters > 2 > cash Flow > depreciation
8140
Quarters > 2 > cash Flow > change In Working Capital
11818100
Quarters > 2 > cash Flow > cash From Operations
9956800
Quarters > 2 > cash Flow > capital Expenditures
81900
Quarters > 2 > cash Flow > cash From Investing
-2578300
Quarters > 2 > cash Flow > cash From Financing
-188800
Quarters > 2 > cash Flow > net Change In Cash
7189700
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.09239677305087116
Quarters > 2 > ratios > PB
0.5107164366654608
Quarters > 2 > ratios > ROE
-2.9866171324005184
Quarters > 2 > ratios > ROA
-2.9319467669567665
Quarters > 2 > ratios > FCF
9874900
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
5.57574135525483
Quarters > 2 > health Score
53
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
1791508
Quarters > 3 > income Statement > cost Of Revenue
612560
Quarters > 3 > income Statement > gross Profit
1178948
Quarters > 3 > income Statement > operating Expenses
3735347
Quarters > 3 > income Statement > operating Income
-2556399
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-2034135
Quarters > 3 > income Statement > net Income
-2034135
Quarters > 3 > income Statement > eps
-0.16210168982585346
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
12548512
Quarters > 3 > income Statement > income Tax Expense
-102118
Quarters > 3 > income Statement > EBITDA
-2647970
Quarters > 3 > income Statement > operating Margin
-142.69537172036073
Quarters > 3 > income Statement > total Other Income Expense Net
522264
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
16596268
Quarters > 3 > balance Sheet > short Term Investments
4024850
Quarters > 3 > balance Sheet > receivables
6409214
Quarters > 3 > balance Sheet > inventories
603934
Quarters > 3 > balance Sheet > total Current Assets
35414095
Quarters > 3 > balance Sheet > property Plant Equipment
52
Quarters > 3 > balance Sheet > total Assets
41457915
Quarters > 3 > balance Sheet > payables
170012
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1082043
Quarters > 3 > balance Sheet > equity
40375872
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-2034135
Quarters > 3 > cash Flow > depreciation
10547
Quarters > 3 > cash Flow > change In Working Capital
-7337600
Quarters > 3 > cash Flow > cash From Operations
-10121401
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-2161900
Quarters > 3 > cash Flow > cash From Financing
-379600
Quarters > 3 > cash Flow > net Change In Cash
-12662901
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.16210168982585346
Quarters > 3 > ratios > PB
0.49105190743620347
Quarters > 3 > ratios > ROE
-5.037996454912479
Quarters > 3 > ratios > ROA
-4.906505790269482
Quarters > 3 > ratios > FCF
-10121401
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-5.649654369391596
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
4647689
Annuals > 0 > income Statement > cost Of Revenue
1702145
Annuals > 0 > income Statement > gross Profit
2945543
Annuals > 0 > income Statement > operating Expenses
6569378
Annuals > 0 > income Statement > operating Income
-3623835
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-2737437
Annuals > 0 > income Statement > net Income
-2045757.4
Annuals > 0 > income Statement > eps
-0.1621908059412955
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
12613276
Annuals > 0 > income Statement > income Tax Expense
-692663
Annuals > 0 > income Statement > EBITDA
-3419295
Annuals > 0 > income Statement > operating Margin
-77.9706860764565
Annuals > 0 > income Statement > total Other Income Expense Net
886397
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
9098122
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
545828
Annuals > 0 > balance Sheet > inventories
901400
Annuals > 0 > balance Sheet > total Current Assets
14956357
Annuals > 0 > balance Sheet > property Plant Equipment
347360
Annuals > 0 > balance Sheet > total Assets
39025310
Annuals > 0 > balance Sheet > payables
216123
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
884033
Annuals > 0 > balance Sheet > equity
38141276
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-2045800
Annuals > 0 > cash Flow > depreciation
30800
Annuals > 0 > cash Flow > change In Working Capital
12079200
Annuals > 0 > cash Flow > cash From Operations
9860300
Annuals > 0 > cash Flow > capital Expenditures
402600
Annuals > 0 > cash Flow > cash From Investing
-17169600
Annuals > 0 > cash Flow > cash From Financing
-188800
Annuals > 0 > cash Flow > net Change In Cash
-7498200
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.1621908059412955
Annuals > 0 > ratios > PB
0.5142367072354894
Annuals > 0 > ratios > ROE
-5.3636312534483634
Annuals > 0 > ratios > ROA
-5.242129787053581
Annuals > 0 > ratios > FCF
9457700
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
2.0349253144950104
Annuals > 0 > health Score
53
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
3183586
Annuals > 1 > income Statement > cost Of Revenue
1353931
Annuals > 1 > income Statement > gross Profit
1829655
Annuals > 1 > income Statement > operating Expenses
1361973
Annuals > 1 > income Statement > operating Income
-5340589
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-4684316
Annuals > 1 > income Statement > net Income
-4685300
Annuals > 1 > income Statement > eps
-0.3685375745031433
Annuals > 1 > income Statement > dividends Per Share
1933600
Annuals > 1 > income Statement > shares Outstanding
12713222
Annuals > 1 > income Statement > income Tax Expense
1555954
Annuals > 1 > income Statement > EBITDA
-4664254
Annuals > 1 > income Statement > operating Margin
-167.7538788020804
Annuals > 1 > income Statement > total Other Income Expense Net
656272
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
16596268
Annuals > 1 > balance Sheet > short Term Investments
4024850
Annuals > 1 > balance Sheet > receivables
6249983
Annuals > 1 > balance Sheet > inventories
603934
Annuals > 1 > balance Sheet > total Current Assets
35254862
Annuals > 1 > balance Sheet > property Plant Equipment
52
Annuals > 1 > balance Sheet > total Assets
41457915
Annuals > 1 > balance Sheet > payables
170012
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1082043
Annuals > 1 > balance Sheet > equity
40375872
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-4685300
Annuals > 1 > cash Flow > depreciation
21000
Annuals > 1 > cash Flow > change In Working Capital
-5080100
Annuals > 1 > cash Flow > cash From Operations
-10263600
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-2027899
Annuals > 1 > cash Flow > cash From Financing
-2372200
Annuals > 1 > cash Flow > net Change In Cash
-14663700
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.3685375745031433
Annuals > 1 > ratios > PB
0.4896255914918692
Annuals > 1 > ratios > ROE
-11.60420758219166
Annuals > 1 > ratios > ROA
-11.301340166286703
Annuals > 1 > ratios > FCF
-10263600
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-3.223911651829101
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
38488237
Annuals > 2 > income Statement > cost Of Revenue
28586951
Annuals > 2 > income Statement > gross Profit
9901286
Annuals > 2 > income Statement > operating Expenses
14435099
Annuals > 2 > income Statement > operating Income
-4533810
Annuals > 2 > income Statement > interest Expense
772.5
Annuals > 2 > income Statement > pretax Income
-4364476
Annuals > 2 > income Statement > net Income
-3724237
Annuals > 2 > income Statement > eps
-0.28861612801155134
Annuals > 2 > income Statement > dividends Per Share
6451900
Annuals > 2 > income Statement > shares Outstanding
12903773
Annuals > 2 > income Statement > income Tax Expense
-640239
Annuals > 2 > income Statement > EBITDA
-4354480
Annuals > 2 > income Statement > operating Margin
-11.779728959785816
Annuals > 2 > income Statement > total Other Income Expense Net
169334
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
31259985
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
8726363
Annuals > 2 > balance Sheet > inventories
1621638
Annuals > 2 > balance Sheet > total Current Assets
46029744
Annuals > 2 > balance Sheet > property Plant Equipment
322
Annuals > 2 > balance Sheet > total Assets
49475360
Annuals > 2 > balance Sheet > payables
371193
Annuals > 2 > balance Sheet > short Term Debt
1
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2042012
Annuals > 2 > balance Sheet > equity
47433347
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-3724200
Annuals > 2 > cash Flow > depreciation
9200
Annuals > 2 > cash Flow > change In Working Capital
18194400
Annuals > 2 > cash Flow > cash From Operations
13144800
Annuals > 2 > cash Flow > capital Expenditures
3306000
Annuals > 2 > cash Flow > cash From Investing
-3306000
Annuals > 2 > cash Flow > cash From Financing
-6602700
Annuals > 2 > cash Flow > net Change In Cash
3241700
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.28861612801155134
Annuals > 2 > ratios > PB
0.42302237316291424
Annuals > 2 > ratios > ROE
-7.851516360420445
Annuals > 2 > ratios > ROA
-7.527458112482659
Annuals > 2 > ratios > FCF
9838800
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
0.25563135043052243
Annuals > 2 > health Score
53
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
162723123
Annuals > 3 > income Statement > cost Of Revenue
108975175
Annuals > 3 > income Statement > gross Profit
53747948
Annuals > 3 > income Statement > operating Expenses
17833870
Annuals > 3 > income Statement > operating Income
38809040
Annuals > 3 > income Statement > interest Expense
52352
Annuals > 3 > income Statement > pretax Income
38755912
Annuals > 3 > income Statement > net Income
29723387
Annuals > 3 > income Statement > eps
2.3034648083161415
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
12903773
Annuals > 3 > income Statement > income Tax Expense
9032525
Annuals > 3 > income Statement > EBITDA
38818240
Annuals > 3 > income Statement > operating Margin
23.84973892124723
Annuals > 3 > income Statement > total Other Income Expense Net
-53125
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
28018306
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
32514314
Annuals > 3 > balance Sheet > inventories
17947928
Annuals > 3 > balance Sheet > total Current Assets
78999351
Annuals > 3 > balance Sheet > property Plant Equipment
592
Annuals > 3 > balance Sheet > total Assets
79149412
Annuals > 3 > balance Sheet > payables
1992540
Annuals > 3 > balance Sheet > short Term Debt
150000
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
21539940
Annuals > 3 > balance Sheet > equity
57609471
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
29723387
Annuals > 3 > cash Flow > depreciation
9566
Annuals > 3 > cash Flow > change In Working Capital
-29628700
Annuals > 3 > cash Flow > cash From Operations
8161899
Annuals > 3 > cash Flow > capital Expenditures
1400
Annuals > 3 > cash Flow > cash From Investing
-1400
Annuals > 3 > cash Flow > cash From Financing
18694100
Annuals > 3 > cash Flow > net Change In Cash
26854648
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
2.3034648083161415
Annuals > 3 > ratios > PB
0.34829979631300556
Annuals > 3 > ratios > ROE
51.594618877857776
Annuals > 3 > ratios > ROA
37.55351587450833
Annuals > 3 > ratios > FCF
8160499
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.05014959674784511
Annuals > 3 > health Score
78
Valuation > metrics > PE
-0.06688944252072182
Valuation > metrics > PB
0.5343235551924936
Valuation > final Score
70
Valuation > verdict
46.6% Undervalued
Profitability > metrics > ROE
-2.2620635906655715
Profitability > metrics > ROA
-8.35759712260005
Profitability > metrics > Net Margin
-0.34772948241703305
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.01861265479924824
Risk > metrics > Interest Coverage
-28.917105141696666
Risk > final Score
-56
Risk > verdict
High
Liquidity > metrics > Current Ratio
66.51345759785997
Liquidity > metrics > Quick Ratio
63.44358350958339
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
49
Prev Risks > 1
-1046
Prev Risks > 2
43
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-22T21:21:50.955Z
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. It offers rapid diagnostic tests, such as family planning, and preventive healthcare line products. The company also develops and commercializes immunochromatographic lateral flow tests; and tests for hospitals and medical practices. The company is headquartered in Marburg, Germany.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of NanoRepro AG
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.